Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing ...

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), announces the company will attend the 2025 EAACI Congress in Glasgow, UK, on June 13-16.

8 However, advances from the laboratory bench have not been paralleled by advancement in clinical practice, leading to a large knowledge gap and many unanswered questions regarding the acute and ...

7 Royal Surrey County Hospital NHS Foundation Trust and Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Biochemical Approach for Diagnosing Myocardial Injury and Infarction e634 35. Applying Imaging in Acute Myocardial Infarction e641 36. Applying Imaging in Late Presentation of Myocardial Infarction ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following ...

A 30-year-old man presented to the hospital with acute shortness of breath and generalised urticaria. He had no known preexisting conditions or allergies. The patient reported that his symptoms ...

In this article, we take a close look at a range of treatments for allergic reactions, depending on a person’s symptoms and their severity, including anaphylaxis. Close to one-third of all ...

“We are thrilled to offer the first and only ready-to-use autoinjector for patients suffering from acute migraine and cluster headaches. Physicians are familiar with DHE, which is an effective and ...

However, each child may experience symptoms differently. Anaphylaxis, a sudden, life-threatening reaction of shock to the whole body, is a severe, life-threatening reaction. It does not take much of ...